Status:
UNKNOWN
Impact of Neurophysiological Facilitation of Respiration in Preterm Neonates
Lead Sponsor:
Asir John Samuel
Conditions:
Neonatal Respiratory Distress Syndrome
Eligibility:
All Genders
1-8 years
Phase:
NA
Brief Summary
Background: Respiratory distress syndrome (RDS) or Neonatal respiratory distress syndrome (NRDS) is characterized by pulmonary insufficiency, in preterm neonates and is the major cause of death in pre...
Detailed Description
1. Introduction: Respiratory distress syndrome (RDS) or Neonatal respiratory distress syndrome (NRDS) is characterized by pulmonary insufficiency, in preterm neonates and is the major cause of dea...
Eligibility Criteria
Inclusion
- Neonates within eight days of birth Neonates born before 37 weeks of gestation Neonates diagnosed with Respiratory distress syndrome
Exclusion
- Medically unstable neonates Neonates who undergone recent surgery or congenital disorder
Key Trial Info
Start Date :
September 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 20 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04019886
Start Date
September 2 2020
End Date
January 20 2021
Last Update
March 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neonatal Intensive Care Unit
Ambāla, Haryana, India, 133207